Can new fungal probiotics help with inflammatory bowel disease (IBD)?

Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, involves chronic gut inflammation. Emerging research is exploring whether probiotics derived from fungi may influence the gut microbiome and immune response. In this episode, we examine what is known and what remains experimental in Europe.

In this episode, we cover:

• What IBD is (immune-mediated inflammation of the gastrointestinal tract)

• The difference between Crohn’s disease and ulcerative colitis

• The role of the gut microbiome in intestinal inflammation

• How fungal probiotics differ from bacterial probiotics

• Early research findings and limitations

• Standard medical treatments (5-ASA, corticosteroids, biologics)